In both the CGGA (all grades, n = 297) and TCGA (glioblastoma, n = 418) array datasets, patients with strong EFEMP2 expression were primarily harboring wild type IDH1, whereas most of the ones with low EFEMP2 expression harbored IDH1 mutation (Figure 1C). This evidence concerns the gene IDH1 and glioblastoma.